WISE-2B Brain Study (Weight Loss Intervention Surgical Effects on Brain Function)
NCT06861790 is an interventional trial sponsored by University of Florida. As of 21 Nov 2026, it is recruiting participants. It studies Diabetes and Weight Loss. The registry lists an enrollment of 120 participants at 1 site in 1 country. The registry lists a start date of 10 Nov 2025 and a primary completion date of 31 Dec 2027.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT06861790 |
| Status | Recruiting |
| Study type | Interventional trial |
| Lead sponsor | University of Florida |
| Enrollment | 120 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Diabetes and Weight Loss |
| Start | 10 Nov 2025 |
| Primary completion | 31 Dec 2027 |
| Study completion | 31 Dec 2027 |
| Last update posted | 16 Nov 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Eric Porges, PhD
University of Florida
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Florida - College of Public Health and Health Professions
Gainesville
Bashar Qumseya, MD, MPHCarlos Delgado, MDCrystal Johnson-Mann, MDEric Porges, PhDJohn Williamson, PhDKathryn Ross, PhDRonald Cohen, PhDSomnath Datta, PhDRecruiting
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT06861790
Each answer restates registry values shown on this page.
What is NCT06861790?
NCT06861790 is an interventional trial sponsored by University of Florida. It studies Diabetes and Weight Loss.
Is NCT06861790 recruiting?
As of 21 Nov 2026, it is recruiting participants. 1 of its 1 sites list their own status as recruiting.
Who leads NCT06861790?
The registry names Eric Porges, PhD (principal investigator, University of Florida) as the overall official.
Where does NCT06861790 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When is NCT06861790 expected to complete?
The registry lists a primary completion date of 31 Dec 2027 and a study completion date of 31 Dec 2027. The sponsor last updated the record on 16 Nov 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.